Conclusion: Pancreatic head resection is an alternative where endoscopic interventions have failed, but only after careful selection. QoL improved in 61.5% of our patients and most would recommend surgery. Background and purpose: The purpose of this study is to evaluate the clinical impact of preoperative nutritional support for malnourished cancer patients. Methods: A total of 90 patients, 45 patients with nutrition support group and 45 patients with well-nourish group, in anticipating major surgery of pancreato-biliary cancer were enrolled in this study. We evaluated nutrition status by weight loss (>10% within 6 months), Patient-Generated Subjective Global Assessment (PG-SGA) grade B or C, serum albumin level (<3.0 g/dl) and assigned malnourished patients to the nutrition support group. Results: The postoperative complication rate in the nutrition support group was 51.1% and 42.2% in well-nourish group. The postoperative complications and day of hospital stay after operation were not different between each group. Although the patients whose nutritional status improved after nutritional support showed lower complication rate than other patients whose nutritional status were not improved, the complications rate in these patients were inferior to wellnourished patients. postoperative length of stay of subgroup (PG-SGA grade B/C à B/C) was marginally longer than that of well-nourished group (21.0 vs. 15.0 days, p = 0.050). Initial body mass index (OR, 1.49; 95% CI, 1.07e2.07; p = 0.020) and the amount of protein supplied (OR, 1.84; 95% CI 1.21e2.80; p= 0.004) were independently inhibit the nutritional improvement in malnutrition group. Conclusion: It is suggested that preoperative nutritional support in malnutritional pancreato-biliary cancer patients may be helpful to improve the clinical outcomes, but the postoperative results were still inferior to well-nourished patients in clinical implications.
Introduction: Traditional initial settings on the intravenous patient-controlled analgesia (IV-PCA) pump can represent a significant source of postoperative opioid exposure. The primary aim of this study was to evaluate the impact of first-day IV-PCA use on total inpatient opioid use after pancreatectomy. Methods: Clinical characteristics and total inpatient oral morphine equivalent (OME, e.g. 5 mg hydrocodone=5mg morphine=0.5mg IV hydromorphone) utilization were downloaded from electronic records for pancreatectomy patients treated with IV-PCA at a single institution from 3/ 2016-8/2017. Regression analyses were performed to identify predictors of total usage, highest vs. lowest quartiles of OME, as well as ideal first-day PCA limit. Results: Of 158 consecutive patients in the study period, 132 were provided IV-PCA, which was almost universally (89.4%) paired with concomitant transverse abdominus plane (TAP) block. Median total OME in IV-PCA patients was 525mg (range 28e4,362 mg), with 373mg representing the median proportion ascribed to the IV-PCA. LOS and IV-PCA (both p < 0.001) were independently associated with total OME on linear regression. The optimal firstday IV-PCA OME cutoff using Youden index was 56mg. Using logistic regression, only first-day IV-PCA OME <56 mg independently predicted being in the lowest/ideal quartile of total OME (OR-72.5, p < 0.001). Blood loss (log transformation, OR-1.99, p = 0.01) and first-day IV-PCA 56 mg (OR-7.91, p< 0.001) were independent predictors of being in the highest/worst quartile. Conclusions: Initial IV-PCA utilization is a major predictor of total post-pancreatectomy inpatient OME. Even when using a TAP block, limiting the initial IV-PCA dosing and optimizing the non-narcotic bundle may result in reduced inpatient exposure to opioids. Electronic Posters (EP02A-EP02F) e Pancreas S679
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